← Leaderboards
Robert I Glazer
Georgetown University
$2,618,936
Attributed
$2,618,936
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $286.5K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,618,936 · 3
By mechanism
R01$2,308,536 · 2
R21$310,400 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Joyce Marie Slingerland$12,812,016
- Susette C Mueller$4,209,997
- Jeanine M. Genkinger$8,629,090
- Seyedehfatemeh Razavipour$75,768
- Dean Rosenthal$2,524,646
Others in their field
Top investigators on “Protein Kinase”
- David Heimbrook · Leidos Biomedical Research, Inc.$63,024,346
- Asrar B. Malik · University Of Illinois At Chicago$42,318,340
- John Blenis · Harvard University (Medical School)$31,872,790
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$25,670,024
- Michael H Nathanson · Yale University$25,355,113
- Joel S Greenberger · University Of Pittsburgh At Pittsburgh$24,937,005
Research focus
Protein KinaseMcf7 CellApoptosisIsozymesCell LineCollaborationsAccountingCooperative Breast Cancer Tissue ResourceAnchorage-Independent GrowthAntisense Nucleic AcidAthymic MouseAnimal ModelBcl2 Gene /ProteinAnimalsCellsBreast NeoplasmsBreast CarcinomaAgonistCancer Cell LineCarcinogenesisBreast Cancer CellBreast AdenocarcinomaCell ProliferationAntigens
Grant awards (11)
PDK1 and PPARdelta Signaling in Mammary Tumorigenesis$266,540
R01 · FY2010 · CA · contact PI
PDK1 and PPARdelta Signaling in Mammary Tumorigenesis$266,540
R01 · FY2009 · CA · contact PI
PDK1 and PPARdelta Signaling in Mammary Tumorigenesis$286,495
R01 · FY2008 · CA · contact PI
PDK1 and PPAR-delta Signaling in Mammary Tumorigenesis$266,540
R01 · FY2007 · CA · contact PI
PDK1 and PPARdelta Signaling in Mammary Tumorigenesis$274,500
R01 · FY2006 · CA · contact PI
AKT PROTOONCOGENE IN BREAST CANCER$241,383
R01 · FY2003 · CA
Structure Based Discovery of AKT Inhibitors$155,200
R21 · FY2003 · CA
AKT PROTOONCOGENE IN BREAST CANCER$234,354
R01 · FY2002 · CA
Structure Based Discovery of AKT Inhibitors$155,200
R21 · FY2002 · CA
AKT PROTOONCOGENE IN BREAST CANCER$250,928
R01 · FY2001 · CA
AKT PROTOONCOGENE IN BREAST CANCER$221,256
R01 · FY2000 · CA